The therapeutic effect of systemic (oral) corticosteroids on the recurrent aphthous stomatitis: A systematic review

Document Type : Review Article(s)

Authors

1 Assistant Professor, Department of Oral Medicine, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

2 Student of Dentistry, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

3 Oral and Dental Diseases Research Center AND Kerman Social Determinants on Oral Health Research ‎Center, Kerman University of Medical Sciences, Kerman, Iran

4 Associate Professor, Department of Oral Medicine, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran

Abstract

BACKGROUND AND AIM: Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity with 5-25% morbidity. Etiopathogenesis is still unclear and there is no certain cure for the disease. This study was conducted systematically to access the therapeutic effects of systemic (oral) corticosteroids on oral aphthae.
METHODS: This systematic review study was conducted according to the Cochrane’s recommended manual, and clinical trial studies that compared oral systemic corticosteroids with placebo or other drugs, were considered eligible to include. For this purpose, keywords were determined using Mesh system and were searched through the Boolean searching method using “and” and “or” in the PubMed, Cochrane Library, Scopus, Web of Science, and Google Scholar databases. In order to increase sensitivity, time and language limitations were not implemented. Afterwards, all of the searched studies were evaluated and the required information was obtained.
RESULTS: In this systematic review, only five clinical trials were involved. In all of the studies, prednisone or prednisolone (the active form of prednisone) was used as a systemic corticosteroid, rather than systemic drugs such as colchicine, sulodexide, montelukast, levamisole, and placebo. In general, this drug was effective in healing aphthous symptoms.
CONCLUSION: There were few clinical trials using systemic corticosteroids. The results of this study showed that low prednisolone dosage combined with levamisole was effective in curing aphthae with no serious side effects.

Keywords

Main Subjects


  1. Porter SR, Hegarty A, Kaliakatsou F, Hodgson TA, Scully C. Recurrent aphthous stomatitis. Clin Dermatol 2000; 18(5): 569-78.
  2. Porter S, Scully C. Aphthous ulcers: Recurrent. Clin Evid 2002; (8): 1397-403.
  3. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 1998; 9(3): 306-21.
  4. Scully C, Porter S. Oral mucosal disease: Recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 2008; 46(3): 198-206.
  5. Chahine L, Sempson N, Wagoner C. The effect of sodium lauryl sulfate on recurrent aphthous ulcers: A clinical study. Compend Contin Educ Dent 1997; 18(12): 1238-40.
  6. Woo SB, Setterfield JF, Greenberg MS. Ulcerative, vesicular, and bullous lesions. In: Glick M, Greenberg MS, Lockhart PB, Challacombe SJ, editors. Burket's oral medicine. 11th Ontario, BC Decker Inc; 2008. p. 41-61.
  7. Porter S, Flint S, Scully C, Keith O. Recurrent aphthous stomatitis: the efficacy of replacement therapy in patients with underlying hematinic deficiencies. Ann Dent 1992; 51(2): 14-6.
  8. Tarakji B, Gazal G, Al-Maweri SA, Azzeghaiby SN, Alaizari N. Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 2015; 7(5): 74-80.
  9. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am 2005; 49(1): 31-viii.
  10. Puri N, Gill JK, Kaur H, Kaur N, Kaur J. Recurrent aphthous stomatitis: Therapeutic management from topicals to systemics. J Adv Med Dent Scie Res 2015;3(2):165-170.
  11. Hunter IP, Ferguson MM, Scully C, Galloway AR, Main AN, Russell RI. Effects of dietary gluten elimination in patients with recurrent minor aphthous stomatitis and no detectable gluten enteropathy. Oral Surg Oral Med Oral Pathol 1993; 75(5): 595-8.
  12. McBride DR. Management of aphthous ulcers. Am Fam Physician 2000; 62(1): 149-54, 160.
  13. Wahba-Yahav AV. Severe idiopathic recurrent aphthous stomatitis: treatment with pentoxifylline. Acta Derm Venereol 1995; 75(2): 157.
  14. Belenguer-Guallar I, Jimenez-Soriano Y, Claramunt-Lozano A. Treatment of recurrent aphthous stomatitis. A literature review. J Clin Exp Dent 2014; 6(2): e168-e174.
  15. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001; 68(3): 201-6.
  16. Sabbagh A, Felemban M. Therapeutic management of recurrent aphthous stomatitis: A review of the growing knowledge. Ann Int Med Dent Res 2016; 2(6): DE01-DE09.
  17. Brocklehurst P, Tickle M, Glenny AM, Lewis MA, Pemberton MN, Taylor J, et al. Systemic interventions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev 2012; (9): CD005411.
  18. Challacombe SJ, Alsahaf S, Tappuni A. Recurrent aphthous stomatitis: Towards evidence-based treatment? Current Oral Health Reports 2015; 2(3): 158-67.
  19. Deepak S, Sharma D. A comprehensive review on aphthous stomatitis, its types, management and treatment available. J Develop Drugs 2018; 7(2): 1000188.
  20. Patel P, Peter R. Recurrent apthous stomatitis: A review with evidence based management. Br J Pharm Med Res 2019 04(04), 1946–51.
  21. Farshi FS, Ozer A, Tavassoli S, Sungur A, Hincal AA. A clinical trial: In vivo studies on dexamethasone sodium phosphate liposomes in the treatment of human Aphthous Stomatitis. J Liposome Res 1996; 6(4): 699-712.
  22. MacPhee IT, Sircus W, Farmer ED, Harkness RA, Cowley GC. Use of steroids in treatment of aphthous ulceration. Br Med J 1968; 2(5598): 147-9.
  23. Merchant HW, Gangarosa LP, Glassman AB, Sobel RE. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol 1978; 45(6): 870-5.
  24. Kiran MS, Vidya S, Aswal GS, Kumar V, Rai V. Systemic and topical steroids in the management of oral mucosal lesions. J Pharm Bioallied Sci 2017; 9(Suppl 1): S1-S3.
  25. Mimura MA, Hirota SK, Sugaya NN, Sanches JA, Migliari DA. Systemic treatment in severe cases of recurrent aphthous stomatitis: An open trial. Clinics (Sao Paulo) 2009; 64(3): 193-8.
  26. Femiano F, Gombos F, Scully C. Recurrent aphthous stomatitis unresponsive to topical corticosteroids: A study of the comparative therapeutic effects of systemic prednisone and systemic sulodexide. Int J Dermatol 2003; 42(5): 394-7.
  27. Pakfetrat A, Mansourian A, Momen-Heravi F, Delavarian Z, Momen-Beitollahi J, Khalilzadeh O, et al. Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial. Clin Invest Med 2010; 33(3): E189-E195.
  28. Femiano F, Buonaiuto C, Gombos F, Lanza A, Cirillo N. Pilot study on recurrent aphthous stomatitis (RAS): A randomized placebo-controlled trial for the comparative therapeutic effects of systemic prednisone and systemic montelukast in subjects unresponsive to topical therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109(3): 402-7.
  29. Sharda N, Shashikanth MC, Kant P, Jain M. Levamisole and low-dose prednisolone in the treatment of reccurent aphthous stomatitis. J Oral Pathol Med 2014; 43(4): 309-16.
  30. Xue Y, Liu J, Zhao W. A comparison of immunomodulatory monotherapy and combination therapy for recurrent aphthous stomatitis. Int J Pharmacol 2018; 14(3): 377-83.